Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Sees Large Drop in Short Interest

Protagenic Therapeutics, Inc. (NASDAQ:PTIX – Get Free Report) was the target of a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 98,400 shares, a decrease of 32.4% from the November 15th total of 145,500 shares. Based on an average daily trading volume, of 379,900 […]

Leave a Reply

Your email address will not be published.

Previous post Jaden McDaniels leads the way for Timberwolves in defense-led win over Lakers
Next post Titan Pharmaceuticals (NASDAQ:TTNP) & SpringWorks Therapeutics (NASDAQ:SWTX) Head to Head Survey